Guardant Health (GH) Sell-Off Makes Neogenomics (NEO) Deal Less Likely - Needham & Company
- Wall Street ends higher, investors juggle Fed nerves with AI enthusiasm
- Apple in talks with Google to use generative AI in iPhones- Bloomberg
- World shares cheer China data, as central banks line up
- Oil prices climb 2% to 4-month high on lower Iraq, Saudi exports
- Meta Platforms is a new Top Pick at Mizuho, analyst sees upside to consensus
- After-hours movers: ANSYS, National CineMedia, and more
- Midday movers: Google, Pepsi rise; Boeing, Zillow fall
- Midday movers: Adobe, Zillow fall; Micron rises
- After-hours movers: Adobe Systems slumps; Rivian, Ulta Beauty gain
- Midday movers: Tesla, Nvidia fall premarket; Robinhood, Dollar General rise
Guardant Health (GH) Said to Decide Against NeoGenomics (NEO) Takeover - Bloomberg
October 4, 2021 6:16 AM EDTGuardant Health (NASDAQ: GH) had decided not to pursue a potential acquisition of NeoGenomics (NASDAQ: NEO), according to Bloomberg, citing people familiar with the matter. It decided against the deal over the weekend.
Shares in Guardant have fallen nearly 20% since talks began.
... MoreGuardant Health's (GH) Potential Deal for NeoGenomics (NEO) Would Be Dilutive to Top Line - Stifel
October 1, 2021 12:57 PM EDTStifel analyst Daniel Arias weighs in on speculation Guardant Health (NASDAQ: GH) is looking to acquire NeoGenomics (NASDAQ: NEO).
Arias said the deal would be dilutive to GH's top-line. He commented: "... we have GH growing 40% in... More
Increasing unusual option volume: IRNT PROG AEZS AVIR NEO OPAD
October 1, 2021 10:12 AM EDTIncreasing unusual option volume: IRNT PROG AEZS AVIR NEO OPAD
... MoreIncreasing unusual option volume: IRNT PROG AEZS AVIR NEO OPAD
October 1, 2021 10:01 AM EDTIncreasing unusual option volume: IRNT PROG AEZS AVIR NEO OPAD
... MorePre-Open Stock Movers 10/01: (NEO) (SPWR) (MRK) Higher; (OMER) (IRNT) Lower (more...)
October 1, 2021 9:27 AM EDTPre-Open Stock Movers:
Omeros Corporation (Nasdaq: OMER) 30% LOWER; announced that the U.S. Food and Drug Administration (FDA) notified the company that, as part of FDAs ongoing review of the companys Biologics License Application (BLA) for narsoplimab in the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA), FDA has identified deficiencies that preclude discussion of labeling and post-marketing requirements/commitments at this time. FDA stated that the notification does not reflect a final decision on the information under review.
IronNet (NYSE:... More
Guardant Health (GH) Said to Weigh Takeover of NeoGenomics (NEO) - Bloomberg
October 1, 2021 9:03 AM EDT(Updated - October 1, 2021 9:05 AM EDT)
Guardant Health (NASDAQ: GH) is exploring an acquisition of NeoGenomics (NASDAQ: NEO), according to Bloomberg, citing people familiar with the matter.
The companies have held talks about a potential deal, and deliberations are ongoing.
... More